GlaxoSmithKline & California research institute create center to study brain disorders

John George Senior Reporter Philadelphia Business Journal GlaxoSmithKline’s building at the Philadelphia Navy Yard Corporate Center John George GlaxoSmithKline is teaming up with the Sanford Burnham Prebys Medical Discovery Institute to study brain function and ways to potentially reverse or slow down neurodegeneration. The London-based pharmaceutical company, which has operations in Philadelphia and Montgomery County, and the independent nonprofit medical research organization has created the SBP-GSK Center for Translational Neuroscience to identify and validate new targets for treating neurological disorders. GlaxoSmithKline’s building at the Philadelphia Navy Yard Corporate Center John George The center will be based at the institute’s campus in La Jolla, Calif. Einstein expanding its Montco footprint Under the three year agreement, GlaxoSmithKline (NYSE: GSK) will provide funding to create and support a research laboratory. The center will…


Link to Full Article: GlaxoSmithKline & California research institute create center to study brain disorders